RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Alprazolam의 항불안 및 항우울 효과에 대한 이중맹 치험 = A Double Blind Clinical Study on Antianxiety and Antidepressant Effects of Alprazolam

      한글로보기

      https://www.riss.kr/link?id=A1995466

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Forty-seven out patients with generalized anxiety disorder by DSM-Ⅲ criteria were randomly assigned to receive ether alprazolam or placebo. The dosage of alprazolam was 1.5 to 2.0㎎ per day and treatment period was 2 weeks. Clinical evaluation with Hamilton's anxiety scale and depression scale were done on the double blind basis before(baseline) and after treatment. The changes from baseline were compared between placebo and active drug groups.
      The result of study showed that alprazolam produced significantly more clinical improvement than did placebo in both anxiety and depression.
      The side effects as anticholinergic effects were not reported for alprazolam as well as placebo. Tolerance and withdrawal symptoms were not noted during the study period of 4 weeks.
      번역하기

      Forty-seven out patients with generalized anxiety disorder by DSM-Ⅲ criteria were randomly assigned to receive ether alprazolam or placebo. The dosage of alprazolam was 1.5 to 2.0㎎ per day and treatment period was 2 weeks. Clinical evaluation with...

      Forty-seven out patients with generalized anxiety disorder by DSM-Ⅲ criteria were randomly assigned to receive ether alprazolam or placebo. The dosage of alprazolam was 1.5 to 2.0㎎ per day and treatment period was 2 weeks. Clinical evaluation with Hamilton's anxiety scale and depression scale were done on the double blind basis before(baseline) and after treatment. The changes from baseline were compared between placebo and active drug groups.
      The result of study showed that alprazolam produced significantly more clinical improvement than did placebo in both anxiety and depression.
      The side effects as anticholinergic effects were not reported for alprazolam as well as placebo. Tolerance and withdrawal symptoms were not noted during the study period of 4 weeks.

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼